SCHEMBL4605063

SCHEMBL4605063

S=C(NN1CCOCC1)C1=NN(c2ccc(Cl)cc2Cl)C(c2ccc(I)cc2)C1

nearest known ligand 0.75

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 12/20 0.75
CNR2 P34972 11/20 0.75
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
MAPT P10636 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
GPR55 Q9Y2T6 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
ALOX15 P16050 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
AKR1C3 P42330 1/20 0.40
HTT P42858 1/20 0.37
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4605991 0.95 CNR1 (0.82) CNR1CNR2CYP1A2CYP2D6MAPT
SCHEMBL4606369 0.92 CNR1 (0.73) CNR1CNR2CYP1A2CYP2D6MAPT
SCHEMBL14620738 0.92 CNR1 (0.73) CNR1CNR2CYP1A2CYP2D6MAPT
SCHEMBL4606250 0.92 CNR1 (0.73) CNR1CNR2CYP1A2CYP2D6MAPT
SCHEMBL4605885 0.91 CNR1 (0.61) CNR1CNR2CYP1A2CYP2D6MAPT
SCHEMBL2018964 0.91 CNR1 (0.91) CNR1CNR2CYP1A2CYP2D6MAPT
SCHEMBL4605679 0.90 CNR1 (0.60) CNR1CNR2CYP1A2CYP2D6MAPT
SCHEMBL4606201 0.90 CNR1 (0.60) CNR1CNR2CYP1A2CYP2D6MAPT
SCHEMBL4607051 0.89 CNR2 (0.70) CNR1CNR2MAPTKDM4EMEN1
SCHEMBL4607836 0.86 CNR1 (0.67) CNR1CNR2CYP2C9GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP claimed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP claimed
WO-2007009688-A1 THIOCARBONYL-SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS CB1 MODULATORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-25 WO claimed
EP-1743887-A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as CB1 modulators LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP claimed
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
WO-2007009688-A1 THIOCARBONYL-SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS CB1 MODULATORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-25 WO disclosed
EP-1743887-A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as CB1 modulators LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP disclosed